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Background: Human excision repair removes UV photoproducts in 30-mers in vitro, but this has not been previously
observed in vivo.
Results:UV photoproducts are removed in vivo as 30-mers in complex with TFIIH both in general repair and in transcription-
coupled repair.
Conclusion: Primary products of excision repair have been isolated in vivo for the first time.
Significance: The study provides novel insights into post-excision steps of human DNA repair.
Nucleotide excision repair is the sole mechanism for remov-
ing the major UV photoproducts from genomic DNA in human
cells. In vitro with human cell-free extract or purified excision
repair factors, the damage is removed from naked DNA or
nucleosomes in the formof 24- to 32-nucleotide-long oligomers
(nominal 30-mer) by dual incisions. Whether the DNA damage
is removed from chromatin in vivo in a similarmanner andwhat
the fate of the excised oligomer was has not been known previ-
ously. Here, we demonstrate that dual incisions occur in vivo
identical to the in vitro reaction. Further, we show that tran-
scription-coupled repair, which operates in the absence of the
XPC protein, also generates the nominal 30-mer in UV-irradi-
ated XP-C mutant cells. Finally, we report that the excised
30-mer is released from the chromatin in complex with the
repair factors TFIIH andXPG. Taken together, our results show
the congruence of in vivo and in vitro data on nucleotide exci-
sion repair in humans.
Nucleotide excision repair (excision repair) is the sole DNA
repair system for removing UV-induced DNA lesions, cyclobu-
tane pyrimidine dimers (CPDs)2 and the (6-4) photoproducts
((6-4)PPs), as well as bulky base adducts induced by numerous
chemical carcinogens and chemotherapeutic agents from the
human genome (1–3). In addition, it plays a backup role in
repairing oxidized and alkylated bases (3). Mutations in genes
encoding excision repair proteins cause the human disease
xeroderma pigmentosum (XP), which is characterized by
extreme sensitivity to sunlight and a 5000-fold increased inci-
dence of skin cancer (4, 5). There are two modes of nucleotide
excision repair: general excision repair, which removes lesions
from the whole genome, and transcription-coupled repair,
which deals with damage in transcribed DNA strands. Human
general excision repair has been reconstituted in vitro from six
repair factors that include the proteins encoded by theXPgenes
aswell as a general transcription factor and an all-purposeDNA
metabolism factor: XPA, RPA, XPC, TFIIH (eight to 10 pro-
teins, including XPB and XPD), XPG, and XPF-ERCCI (6). In
contrast, there is currently no in vitro system for eukaryotic
transcription-coupled repair and, hence, the mechanistic
aspects of this process remain to be elucidated. In this process,
RNA polymerase II stalls at the lesions to initiate repair by exci-
sion repair factors except XPC, which is not needed for tran-
scription-coupled repair (1–3).
Experiments with the in vitro system revealed that following
damage recognition by RPA, XPA, and XPC and proofreading
byTFIIH, theXPGandXPFnucleasesmake incisions at the 6
3 phosphodiester bond 3 and the 20  5 phosphodiester bond
5, respectively, to the damaged base, releasing an oligonucleo-
tide 24- to 32-nt in length (canonical/nominal 30-mer) carrying
the lesion (7–9). The resulting gap is filled byDNApolymerases
/ and ligated to produce a 30-nt repair patch and, thus, com-
plete the repair reaction (10). Although excision repair has been
investigated in considerable detail, the following questions
remain to be addressed. How is the canonical 30-mer released
following the dual incisions? Do the dual incisions proceed by
the same mechanism in vivo as they do in vitro? Do the con-
certed dual incisions occur in XP-C mutant cells, which can
perform transcription-coupled repair but not general genomic
repair? Finally, what happens to the excised oligonucleotides
carrying the DNA damage? Recently, we addressed the ques-
tion of release of the canonical 30-mer in vitro (11). Here we
present data that address the other questions regarding the fun-
damental mechanism of human excision repair.
EXPERIMENTAL PROCEDURES
Cell Lines—A375 cells, a humanmelanoma cell linewith high
excision repair activity, were obtained as described previously
(12). The following human cell lines were purchased from the
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NIGMS Human Genetic Cell Repository (Coriell Institute):
XPA fibroblasts (XP12BE-SV, GM 04429) and XPC fibroblasts
(XP4PA-SV-EB, GM15983) and its complemented cell line
(XP4PA-SE2, GM 04429).
The XPA2 cell line was generated in our laboratory using the
directions of the manufacturer (Invitrogen) to transfect
XPA/ cells (XP12BE-SV) with Lipofectamine 2000 and a
pcDNA3 construct containing XPA with both a 5 FLAG and a
3 6 His epitope. After 3–4 weeks of culturing in DMEM
containing geneticin at 0.4 mg/ml, single clones were picked
and further expanded in geneticin-containingmedium. Expres-
sion of wild-type XPA was verified by Western blot analysis of
whole cell lysates, DNA sequencing of epitope-tagged recom-
binantXPA in genomicDNA, and restoration of excision repair
activity as assayedwith a clonogenicUV survival assay (data not
shown). CHO cell lines were purchased from the ATCC (WT,
AA8; XPG mutant, UV135; XPF mutant, UV41) or obtained
fromLHThompson, Lawrence LivermoreNational Laboratory
(CSB mutant, UV61).
Mammalian cells were cultured in Dulbecco’s modified
Eagle’s medium supplemented with 10% fetal bovine serum at
37 °C in a 5% CO2 humidified chamber. The XP4PA-SE2- and
XPA2-transfected cells were maintained under the same con-
ditions with the addition of 0.2 mg/ml hygromycin B or geneti-
cin, respectively.
Antibodies—Antibodies used for immunoprecipitation (IP)
included anti-mouse IgG (catalog no. sc-2025), anti-rabbit IgG
(catalog no. sc-2027), anti-XPB (catalog no. sc-293), anti-XPA
(catalog no. sc-28353), anti-p62 (catalog no. sc-292), and anti-
XPC (catalog no.sc-74410) from Santa Cruz Biotechnology;
anti-RPA34 (catalog no. NA18) from Calbiochem; anti-XPG
(catalog no. A301-485A) from Bethyl; anti-XPF (catalog no.
ab17798) and rabbit anti-mouse IgG (catalog no. ab46540) from
Abcam; anti-CPD from Kamiya Biomedical; and anti-(6-4)PP
from Cosmo Bio.
Immunoblot detection of most of the proteins involved the
use of the same antibody that was used for IP. RPA and XPA
were detected with antibodies from Bethyl (catalog no. A300-
241A) and Santa Cruz Biotechnology (catalog no. sc-853),
respectively. XPG was detected with antibodies from Santa
Cruz Biotechnology (catalog no. sc-13563) for in vitro reactions
and Bethyl (catalog no. A301-484A) for in vivo IP reactions.
Purification of In Vivo-excised Oligonucleotides Containing UV
Photoproducts—UV irradiation was performed as described pre-
viously (12). Briefly, culture medium was removed, and then
cells were washed once with PBS before placing them under a
GE germicidal lamp emitting primarily 254-nm UV light
(UV-C) connected with a digital timer. Following irradiation,
fresh culture medium was added to the cells, which were fur-
ther incubated for the indicated length of time. TheXP-C fibro-
blasts and their complemented derivative were irradiated with
20 J/m2 of UV-C, and other cells were exposed to 10 J/m2 of
UV-C. At the indicated time points, the cells were washed with
ice-cold PBS, harvested with a cell scraper in ice-cold PBS, and
collected by centrifugation. Low molecular weight DNA was
isolated by amodifiedHirt procedure (13). Cell pellets fromone
150-mm tissue culture dish (100 l of packed cell volume)
were resuspended in 400 l of buffer P1 (10 mM Tris-Cl
(pH8.0), 1mMEDTA, and 100g/ml RNase A), lysed by adding
55 l of 10% SDS, and incubated for 15 min at room tempera-
ture. Then, 140 l of 5 M NaCl was added, and the tubes were
inverted gently 10 times and stored for at least 8 h at 4 °C.
Genomic DNAwas removed by centrifugation in an Eppendorf
5418microcentrifuge atmaximum speed (16,873 g) for 1 h at
4 °C. The supernatant ( 550 l) was treated with 20 g of
proteinase K for 15 min at 55 °C, extracted with phenol/chlo-
roform twice, and then precipitated with ethanol. The pellet
was washed with 500 l of 70% ethanol and resuspended in 10
l of buffer EB (10 mM Tris-Cl (pH8.5)).
The extracted low molecular weight DNA was subjected to
immunoprecipitation with anti-CPD or anti-(6-4)PP antibod-
ies as follows: For each reaction, 5 l of protein G Dynabeads
(Invitrogen, catalog no. 10003D) slurry and 5 l of anti-rabbit
Dynabeads (Invitrogen, catalog no. 11203D) slurry were
washed three times with 50 l of wash buffer I (20 mM Tris-Cl
(pH8.0), 2mMEDTA, 150mMNaCl, 1%TritonX-100, and 0.1%
SDS) and then incubatedwith 1l of rabbit anti-mouse IgG and
1 l of anti-CPD or anti-(6-4)PP antibody in 20 l of IP buffer
(20mMTris-Cl (pH 8.0), 2 mM EDTA, 150mMNaCl, 1% Triton
X-100, and 0.5% sodium deoxycholate) for 3 h at 4 °C. After
incubation, beads were separated from the liquidwith amagnet
and then mixed with 100 l of IP buffer and 10 l of DNA. The
mixtures were rotated at 4 °C overnight. The beads were then
washed sequentially with 200 l each of wash buffer I, wash
buffer II (20 mM Tris-Cl (pH 8.0), 2 mM EDTA, 500 mM NaCl,
1%TritonX-100, and 0.1% SDS), wash buffer III (10mMTris-Cl
(pH 8.0), 1 mM EDTA, 150 mM LiCl, 1% Nonidet P-40, and 1%
sodium deoxycholate), wash buffer IV (100 mM Tris-Cl (pH
8.0), 1 mM EDTA, 500 mM LiCl, 1% Nonidet P-40, and 1%
sodium deoxycholate) and finally twice with TE (10mMTris-Cl
(pH8.0) and 1mMEDTA). The oligonucleotides containingUV
photoproducts were eluted by incubationwith 100l of elution
buffer (50 mM NaHCO3, 1% SDS, and 20 g/ml glycogen) at
65 °C for 15min. The eluted DNAwas then isolated by phenol/
chloroform extraction and followed by ethanol precipitation.
Immunoprecipitation of In Vivo Excision Products—Cell pel-
lets from one 150-mm tissue culture dish were resuspended in
800 l of ice cold buffer A (25mMHepes (pH 7.9), 100mMKCl,
12 mM MgCl2, 0.5 mM EDTA, 2 mM DTT, 12.5% glycerol, 0.5%
Nonidet P-40) and incubated for 10 min on ice. Resuspended
cells were transferred to an ice-cold Dounce homogenizer/tis-
sue grinder and lysed on ice with 15 strokes using a tight
plunger. The chromatin fraction was then pelleted by centrifu-
gation for 30 min at 16,873  g at 4 °C. The supernatants were
harvested, and appropriate antibodies against repair proteins
(typically 2–5 g), as described above, were added. The reac-
tions were rotated for 3–5 h at 4 °C and then incubated over-
night with 10 l of recombinant protein A/G PLUS-agarose
(Santa Cruz Biotechnology). After washing three times with 1
ml of buffer A and once with 1ml of buffer B (25mMHepes (pH
7.9), 100 mM KCl, 12 mM MgCl2, 0.5 mM EDTA, 2 mM DTT,
12.5% glycerol, 1% Nonidet P-40), immunoprecipitates were
eluted with 400 l of buffer C (10 mM Tris-Cl (pH 7.5), 1 mM
EDTA, and 1% SDS) at 65 °C for 15 min. The low molecular
weightDNA from input, flowthrough, and immunoprecipitates
were extracted by the modified Hirt procedure as described
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above. These DNAs were either radiolabeled directly or sub-
jected to a second round of IP with anti-CPD or anti-(6-4)PP
antibodies prior to labeling.
DNA Labeling—For 3-end labeling, the immunoprecipi-
tatedDNAwas incubatedwith 20 units of terminal deoxynucle-
otidyl transferase (NEB) and 1 Ci of [-32P]3-deoxyadenos-
ine 5-triphosphate (cordycepin 5-triphosphate) (PerkinElmer
Life Sciences) for 1 h at 37 °C in 50 l of total reaction buffer
according to the protocol of themanufacturer. For 5 end label-
ing, the immunopurified DNA was treated with 1 unit of
FastAP thermosensitive alkaline phosphatase (Thermo) in 45
l of 1 T4 polynucleotide kinase buffer (NEB) for 20 min at
37 °C. After heat inactivation (75 °C, 5 min), the reaction was
incubated with 10 units of T4 polynucleotide kinase (NEB) and
3 Ci of [-32P]ATP (MP Biomedicals) for 1 h at 37 °C. The
labeling reaction was heat-inactivated (65 °C for 20 min) and
then incubated with 1 l of RNaseA/T1 mixture (Thermo) for
30 min at 37 °C to remove contaminating RNAs. After phenol-
chloroform extraction and ethanol precipitation, labeled
DNAs were resolved in 11% denaturing sequencing gels. For
exonuclease digestion assays, the labeled DNA was purified
through G25 gel filtration columns (GE Healthcare) before
ethanol precipitation.
Exonuclease Digestion Assay—For 53 3 digestion, 3 end-
labeled DNA was incubated with 22.5 units of RecJf (NEB) for
1 h at 37 °C in a 5-l reaction according to the recommenda-
tions of themanufacturer. For 33 5 digestion, 5 end-labeled
DNA was incubated with 0.6 units of T4 DNA polymerase
(NEB) for 1 h at 37 °C in a 4-l reaction according to the rec-
ommendations of themanufacturer. Reactionswere stopped by
adding 10l of formamide loading buffer and heating for 5min
at 95 °C. Samples were separated in 11% denaturing sequencing
gels.
In Vitro Excision Repair and Immunoprecipitation Assay—
Internally 32P-labeledDNA substrate (140 bp) containing a sin-
gle (6-4) UV photoproduct and cell-free extract (CFE) were
prepared as described previously (14). Standard excision
assays with XPG (UV135) or XPF (UV41) mutant CHO CFE
complemented by the appropriate proteins were carried out.
Immunoprecipitations with the indicated antibodies were
then performed as described previously (11). A 25-l reaction
contained 75 g of CFE, 24 ng of purified human XPG (for
UV135), or 15 ng of purified human XPF-ERCCI (for UV41).
Human XPG and XPF-ERCCI proteins were purified as
described (14). The mutant CHO CFE and complemented
human proteins were used because our antibodies did not rec-
ognize hamster XPG and XPF.
Immunoblotting—Proteins from in vitro excision reactions
and from cell lysates of UV-irradiated cells were subjected to
immunoprecipitation with appropriate excision repair factor
antibodies, separated by SDS-PAGE, transferred to Hybond
ECL membranes (GE Healthcare), probed with the indicated
antibodies, and detected with ECL reagents (GE Healthcare).
RESULTS
Recent in vitro experiments on human DNA excision repair
revealed that, following dual incisions, the excised oligomer is
released in a complex with TFIIH (11).We wished to find out if
this happens in vivo as well. However, it was necessary to first
establish that the in vivo and in vitro excision repair patterns
were similar.
Dual Incisions Generate Nominal 30-mers in Vivo—Even
though in vitro experiments have shown that human excision
repair system excises CPD and (6-4)PP by the same dual inci-
sion mechanism on naked DNA (6, 7, 15) and in nucleosomes
(16–18), it was reasonable to assume that the incision pattern
might be different in the higher-order structural organization
of chromatin. Indeed, to date, no study has demonstrated that
UV photoproducts are released as 30-nt-long oligomers in vivo.
Previous studies specifically addressing this question detected
CPD in 4- to 6-nt-long oligomers (19–21). However, it could
not be ascertained whether these were primary or processed
reaction products (21).
To detect the excised oligonucleotides containing UV pho-
toproducts, we used a modified Hirt procedure to purify low
molecular weight DNA from irradiated cells incubated for var-
ious time periods after irradiation. The DNA was then immu-
noprecipitated with either anti-CPD or anti-(6-4)PP antibod-
ies, 3-radiolabeled, and analyzed on a sequencing gel (Fig. 1
and supplemental Fig. S1). Oligonucleotides in the range of
20–30 nucleotides were detected in the A375 human cell line,
leading us to conclude that the in vivo excision pattern is similar
to the in vitro pattern. To ensure the specificity of the detected
signal, we used an XP-Amutant cell line and its complemented
derivative. Although the XP-A cell line XP12BE, which is
severely defective in nucleotide excision repair because of a
splice site mutation (22), showed little to no excision product
formation, the complemented derivative excised oligonucleo-
tides containing (6-4)PPs similar to the A375 cell line (Fig. 1, B
and C).
Two points are worth noting in Fig. 1. First, in agreement
with the in vitro data and with in vivo data that measure the
disappearance of UV photoproducts from genomic DNA by
immunochemical methods (ELISA and slot blot), the (6-4)PPs
are removed more rapidly than the CPDs (8, 12, 23). Second,
although at earlier time points species in the range of 25–30 nt
dominate for both photoproducts, at later time points, smaller
size products become more abundant. As will be shown below,
this is due to the relatively rapid degradation of the primary
excision products.
Mode of Dual Incision in Vivo—In vitro experiments with
numerousDNA lesions have shown that human excision repair
removes the DNA lesion in the form of 24- to 32-nt-long olig-
omers by incising the 20  5th phosphodiester bond 5 and the
6 3rd phosphodiester bond 3 to the damage,with the specific
incision sites being influenced by the type of DNA damage, and
the surrounding sequence (1, 2, 15, 18). To find outwhether this
pattern, which was observed with naked DNA and DNA in
nucleosomes, also holds for DNA in chromatin, we recovered
the excision products from early time points after UV irradia-
tion so that we would be workingmainly with the primary exci-
sion products and then analyzed them. To determine the 3
incision site, the excised oligonucleotides were immunopre-
cipitated with anti-(6-4)PP or anti-CPD antibodies and then
treated with Escherichia coli RecJ exonuclease, which hydro-
lyzes single-strandedDNA in the 5-to-3 direction and stops at
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the photoproduct (24). The results are shown in Fig. 2A. Both
(6-4)PPs and CPDs in the range of 23–29 nt before nuclease
treatment (Fig. 2A, lanes 1 and 3) give rise to fragments 6–9 nt
in length after RecJ digestion (lanes 2 and 4). To identify the 5
incision site, we first immunoprecipitated with antibodies
against the p62 subunit of TFIIH. Previous in vitro work (11)
has shown that the primary excision products are released in a
tight complexwithTFIIH.Hence, by first immunoprecipitating
TFIIH, we eliminate degradation products that would interfere
with incision site determination. Then, the TFIIH-associated
oligonucleotides were immunoprecipitated by a second round
of IP with either anti-(6-4)PP or anti-CPD antibodies. The
oligonucleotides were then 5 end-labeled, treated with 3 to 5
exonuclease activity of T4DNApolymerase (25), and separated
on a sequencing gel. Fig. 2B shows that this treatment of 23- to
29-nt long oligomers (lanes 1 and 3) give rise to fragments
18–23 nt in length (lanes 2 and 4). The combined results from
the two exonuclease digestion patterns lead us to conclude that
in vivo incisions occur 17–22 phosphodiester bonds 5 and five
to eight phosphodiester bonds 3 to the photoproducts. These
values are comparable with those obtained in vitro for these
photoproducts under a variety of experimental conditions (3, 7,
9). Thus, we conclude that the human excision nuclease system
performs dual incisions in the same manner on naked DNA,
nucleosomal DNA (16, 17), and DNA in chromatin.
Mode of Dual Incision in General Repair and in Transcrip-
tion-coupled Repair—The incision pattern described so far is
on the basis of the excision products generated by general exci-
sion repair that operates on duplexDNA in chromatin aswell as
by transcription-coupled nucleotide excision repair that oper-
ates on photoproducts in the transcription bubble of a stalled
RNA polymerase (26, 27). We wished to analyze the incision
patterns of these two repair modes separately. To this end, we
used a CS-B mutant cell line that is known to have normal
general repair activity but is defective in transcription-coupled
repair (28) and an XP-C mutant cell line that is known to be
defective in general repair but to have normal transcription-
coupled repair (29, 30).
Cells were irradiated with UV-C, and then cell lysates pre-
pared at various times after irradiation were subjected to
immunoprecipitation with anti-p62 (TFIIH) antibodies. The
TFIIH-bound DNA was then extracted, 3 end-labeled, and
analyzed on sequencing gels. As seen in Fig. 3A, in both XP-C
andCS-Bmutant cell lines, the excised oligonucleotideswere in
the same 25- 30-nucleotide range that is observed in wild-type
cells. Thus, it appears that the dual incisions have the same
pattern in transcription-coupled (XP-Cmutant) and transcrip-
tion-independent repair (CS-B mutant). Indeed, analysis of the
excision product of the XP-C mutant by 5 exonuclease diges-
tion revealed the same 5 and 3 incision patterns as in wild-
type cells (supplemental Fig. S2). We note however, that in the
XP-Cmutant it was necessary to use 2-foldmore cells than in
the wild-type control to obtain a comparable repair signal
because transcription-coupled repair contributes about
20–50%of total repair at early time points after irradiation (30).
In contrast, the effect of CSBmutation on the total repair rate is
less drastic (28) and, therefore, with equal numbers of irradi-
ated cells, the excision signal from the CS-B mutant was only
about 20% less than the signal from the wild-type control. We
also noted that the excised oligonucleotides detected in Fig. 3A
include those containing CPD and those containing (6-4)PPs
because theywere isolated byTFIIH immunoprecipitation. The
contributions of these photoproducts to the overall excision
signal was analyzed by immunoprecipitation with photoprod-
uct-specific antibodies and revealed a rather striking difference
between the XP-C mutant and the complemented cell line.
Fig. 3B shows the results of these experiments. Cyclobutane
pyrimidine dimers are notoriously poor substrates for the
FIGURE 1. In vivo-excised oligonucleotides containing UV photoproducts. A, excised oligonucleotides containing CPDs were recovered from A375 cells at
various time points after exposure to 10 J/m2 of UV-C. Because of the slow rate of excision of CPD, at later time points, the secondary excision products
dominate and, therefore, longer exposure of the gel was necessary to detect the primary excision products that are present at early time points. In addition,
because of the low signal-to-noise ratio for CPD at early time points, long exposure reveals small molecular weight radiolabeled species not related to repair.
B, excised oligonucleotides containing (6-4)PPs were recovered from A375 cells at various time points after exposure to 10 J/m2 of UV-C. C, excised oligonu-
cleotides containing (6-4)PPs were obtained from XP-A and its complemented (XPA) cell lines at various time points after exposure to 10 J/m2 of UV-C. For
each sample, low molecular weight DNA was extracted from one 150-mm tissue culture dish of cells by the modified Hirt procedure and then immunopre-
cipitated with anti-CPD or anti-(6-4)PP antibodies, respectively. Purified DNAs were 3 end-labeled and resolved in 11% denaturing sequencing gels. Locations
of primary excision products are indicated by brackets.
Fate of Human UV Damage Excision Products in Vivo
JULY 19, 2013 • VOLUME 288 • NUMBER 29 JOURNAL OF BIOLOGICAL CHEMISTRY 20921
human excision nuclease system, being excised at 10–20% the
rate of excision of (6-4)PPs both in vivo (23) and in vitro (8, 31).
In agreement with these findings, about 70% of the excised
oligonucleotides from the complemented cells contain
(6-4)PPs (Fig. 3B, lanes 5–8). Strikingly, in the XP-C mutant,
the ratio is reversed. Nearly 70% of the excised oligonucleotides
contain CPDs and only about 30% contain (6-4)PPs (Fig. 3B,
lanes 1–4). This seemingly paradoxical finding is the result of a
unique property of transcription-coupled repair. In transcrip-
tion-coupled repair, RNA polymerase II makes a very stable
elongation complex at the site of the UV photoproduct (27, 32),
which is now in part of the transcription elongation bubble (27).
Within such a structure, the rate of excision of the poorly rec-
ognized CPDs is stimulated 5–10-fold, whereas that of effi-
ciently recognized (6-4)PPs is unaffected (31, 33, 34). As a con-
sequence, CPDs and (6-4)PPs in transcription elongation
bubbles are repaired at about the same rate (29). Because at the
UV dose used in our experiments there are about 5 times more
CPDs than (6-4)PPs (23), the probability of CPDs being in a
transcription bubble is 5-fold higher, and because within such a
structure they are repaired at the same rate as the (6-4)PPs, the
excised oligonucleotides are expected to contain more CPDs
than (6-4)PPs, as we observed in our experiments.
Mechanism of Release of the Dual Incision Product In Vivo—
Recent in vitro experiments indicate that the excised oligomer
is released fromDNA in a tight complexwithTFIIH (11). These
experiments also revealed that secondary excision products
produced by nucleolytic degradation of the primary product
were bound by RPA. To find out whether, in fact, in vivo the
primary excision product was released in complex with TFIIH,
we carried out in vitro and in vivo repair experiments in parallel,
immunoprecipitated each of the six excision nuclease factors,
and analyzed the immunoprecipitates for DNA content. The
results are shown in Fig. 4. In agreement with the previous
report, in vitro, TFIIH is bound to the primary excision product
FIGURE 2. Dual incision pattern in vivo. A, the distance between the DNA
lesion and the 3 end of excised oligonucleotides. Total excised oligonucleo-
tides containing (6-4)PPs or CPDs obtained from A375 cells either 30 min or
2 h, respectively, after 10 J/m2 of UV-C were 3 end-labeled with 32P, treated
by the 5 to 3 exonuclease RecJ, and analyzed in a 11% denaturing sequenc-
ing gel. B, the distance between the DNA lesion and the 5 end of primary
excised oligonucleotides. The lysates of A375 cells either 30 min or 2 h after 10
J/m2 of UV-C were immunoprecipitated with anti-p62. DNA from the immu-
noprecipitation reactions were then immunoprecipitated with anti-(6-4)PP or
anti-CPD antibodies, respectively. The double IP-purified DNAs were then 5
end-labeled, treated with the 3 to 5 exonuclease of T4 DNA polymerase, and
analyzed in a 11% denaturing sequencing gel. C, schematic of dual incisions
observed in vivo. The triangle depicts the UV photoproduct in the excised
oligomer. Dual incision sites were mapped using Rec J (A) and the exonu-
clease activity of T4 polymerase (B). The numbers indicate the numbers of
nucleotides 5 and 3 to the photoproducts, respectively.
FIGURE 3. Transcription-coupled excision and general excision products
in vivo from XP-C and CS-B mutant cell lines. A, size of primary excised
oligonucleotides by transcription-coupled repair and general repair. XP-C
human fibroblast and their complemented derivative (XPC) and CHO CS-B
mutant and isogenic wild-type CHO cells were exposed to UV-C and then
harvested and lysed immediately or 30 min after irradiation. Cell lysates were
immunoprecipitated with anti-p62. DNA from the immunoprecipitations
were purified, 3 end-labeled, and then analyzed in a 11% denaturing
sequencing gel. B, XPC-independent repair efficiency of CPDs and (6-4)PPs by
transcription-coupled repair. Total excised oligonucleotides containing
(6-4)PPs or CPDs obtained from an XP-C mutant and its complemented deriv-
ative that were irradiated with 20 J/m2 of UV-C and, 30 min later, were har-
vested for isolation of the excised oligonucleotides by IP with photoproduct-
specific antibodies followed by 3 end-labeling and analysis in a 11%
sequencing gel. The whole image is from the same gel, although the order of
the lanes has been changed for clarity. Excision products were quantified
with ImageQuant 5.2 software (GE Healthcare) and given as numbers relative
to CPD in each set. We note that because anti-CPD and anti-(6-4)PP antibod-
ies have slightly different IP efficiencies, these values should be considered
semiquantitative. Nevertheless, the comparison between the wild-type and
XP-C mutant compensates for this technical limitation. In addition, because
the XP-C mutant cell line has weak excision repair capability (and only tran-
scription-coupled repair), two 150-mm tissue culture dishes of XP-C cells were
used for each sample, whereas just one 150-mm tissue culture dish for each
sample for other cell lines was used in A and B.
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(Fig. 4A, lane 8 in the left and right panels). Of interest, XPG
(Fig. 4A, left panel, lane 9) and to a lesser extent XPF (right
panel, lane 9) also bring down the primary excision product.
These factors were not tested in the previous study (11). In
fact, it appears that XPG strongly interacts with TFIIH (6, 35,
36) and, therefore, that the excision complex is most likely
released in the form of DNA-TFIIH-XPG. There is only weak
interaction between XPF and TFIIH (35), and it is reasonable
to assume that some XPF remains bound to the 5 end (which
is generated by XPF) of the excised oligomer for a period of
time.
Importantly, when the immunoprecipitation reactions were
performed on lysates of UV-irradiated cells 2 h following irra-
diation, essentially identical results were obtained (Fig. 4B).
TFIIH (Fig. 4B, lane 12) and XPG (lane 15) were almost exclu-
sively bound to the primary excision product in the 24- 30-nt
size, whereas RPA was mostly bound to oligonucleotides in the
range of 15–20 nucleotides (lane 10). XPF, as in the in vitro
reaction, was bound to a small fraction of the primary excision
product (Fig. 4B, lane 14).
DISCUSSION
In this study, we have addressed several interrelated ques-
tions regarding the basic mechanism of excision repair. Is the
dual incision pattern from chromatin in vivo the same as the
pattern observedwith nakedDNA in vitro?What is the incision
pattern in transcription-coupled repair observed in XP-C
mutant cells? Is the excision product released from the DNA
duplex in the same manner in vivo and in vitro? Finally, how
stable is the excised oligomer-repair protein complex?
Dual Incision Patterns in Vivo and in Vitro—Our data show
that, within the resolution of our assay, the concerted dual inci-
sion event that was first discovered in vitro with naked DNA is
the manner by which damage is removed from chromatin in
vivo. It is known that, during excision repair in vivo, there is a
considerable amount of covalent and non-covalent structural
changes that facilitate the access of the DNA repair enzymes to
the damage (37). Hence, it is quite likely that the excision repair
system in the course of its assembly at the damage site the DNA
is essentially in the form of a conventional B-form duplex, en-
abling the dual incisions to proceed as it does in the in vitro
FIGURE 4. The primary excised oligonucleotides are released in complex with TFIIH-XPG and XPF both in vitro and in vivo. A, in vitro experiments with
cell-free extracts. The indicated proteins were immunoprecipitated from excision repair reactions with an internally labeled 140-bp-long duplex containing
(6-4)PP with specific antibodies. Left panel, XPG-mutant CHO (UV135) CFE and purified human XPG were used. Right panel, XPF-mutant CHO (UV41) CFE and
purified human XPF-ERCCI were used. DNA from the immunoprecipitations were purified and then analyzed in a 11% denaturing sequencing gel. Immuno-
precipitates were also analyzed by SDS-PAGE and Western blotting. B, in vivo experiments. The indicated proteins were immunoprecipitated with specific
antibodies from A375 cells 2 h after exposure to 10 J/m2 of UV-C. A portion of immunoprecipitates was analyzed by SDS-PAGE and Western blotting. DNA from
the remaining immunoprecipitates were then immunoprecipitated with anti-CPD antibodies, 3 end-labeled, and analyzed in a 11% denaturing sequencing
gel. The XPG immunoprecipitation reaction was performed on extracts from a separate experiment. Locations of the primary excision products are indicated
by brackets. We note that the low titer of the XPG antibody necessitated the use of high amount of antibody in IP experiments that resulted in some background
in Western blots. Thus,  in A, lane 9 (left panel) and B, lane 15 indicate a cross-reacting IgG light chain that migrates in the vicinity of the XPA band. Similarly, the
low amount of XPG in the in vivo experiment and the low titer of the XPG antibody necessitated the use of a high amount of the antibody, which reveals a
cross-reacting band (‡) not related to XPG in the flowthrough of B, lane 8.
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reaction with cell-free extracts or the reconstituted excision
repair system, that is, incisions at the 20th  5 phosphodiester
bond 5 and the 6th 3 phosphodiester bond 3 to the damage.
Dual Incision in the XP-CMutant—It has been reported that
inXP-Cmutant cells, UVphotoproducts in the template strand
of transcribed genes are repaired in an XPC-independent man-
ner and with about the same efficiency as repair elsewhere with
the entire set of excision repair factors (29, 30). Even though the
E. coli transcription-coupled repair has been reconstituted in
vitro (38), currently there is no in vitro system for eukaryotic
transcription-coupled repair. However, it has been found that
RNA polymerase II stalled at a CPD does not inhibit excision of
the photoproduct (27) and that a CPD in a transcription bub-
ble-like substrate can be excised by the five core repair factors in
the absence of XPC (33). However, there was no information
regarding the excision pattern of UV photoproducts in XP-C
mutants in which the excised oligomer is exclusively generated
by transcription-coupled repair. In this study, for the first time,
the sizes of the excision fragments and the pattern of dual inci-
sion in anXP-Cmutant have been determined.We find that the
dual incision initiated by transcription-coupled repair and car-
ried out with five core repair factors along with RNA polymer-
ase II is essentially the same as that generated by the six core
repair factors independently of transcription. It thus appears
that RNA polymerase II stalled at a photoproduct functions
primarily as a damage recognition factor in a manner that XPC
does elsewhere, enabling the five core factors that are present in
the actual dual incision complex, even in transcription-inde-
pendent repair, to assemble at the site of damage with the same
topography and carry out dual incision in the same manner.
Moreover, as both CPD and (6-4)PPs are equally efficient in
blockingRNApolymerase; the polymerase, in turn, functions as
an equally efficient damage recognition factor for both lesions.
This explains their equally efficient removal by transcription-
coupled repair in contrast to their visibly different repair rates
in transcription-independent repair, in which the damage rec-
ognition factors XPC, RPA, and XPA recognize (6-4)PPs more
efficiently than the CPDs.
Release of the ExcisedOligonucleotide—Recentwork revealed
the surprising finding that the excised oligonucleotide is
released in a tight complex with TFIIH (11). Of the other repair
factors tested, XPA and XPCwere not associated with the exci-
sion products, and RPA was found to be bound mainly to the
secondary excision products that were released from TFIIH. In
this study, we have confirmed those findings and have shown
that they are a faithful representation of the in vivo events, as
the same results were obtained with the in vivo-generated exci-
sion products. Furthermore, in this work, we have also tested
the two nucleases that are responsible for generating the dual
incisions for their associations with the nuclease excision prod-
uct.We have found that XPG is bound as tightly as TFIIH to the
excision product, but this appears to be the consequence of
tight association between XPG and TFIIH (6, 35). In contrast,
XPF binds onlyweakly to the excised oligomer, and this binding
appears to be independent of TFIIH. Taking these findings and
the known protein-protein interactions among the six excision
repair factors into account, we propose a modified form of the
recently reportedmodel formammalian excision repair (Fig. 5).
The primary excision product is released in the form of DNA
(nominal 30-mer)-TFIIH-XPG, andTFIIH andXPGare in con-
tact with one another and with the oligomer within the ternary
complex. Some of the excised oligomer is also bound to XPF at
the 5 terminus, but this association is weaker than that of
TFIIH and XPG and, as a consequence, only a fraction of
excised oligomer-protein complexes contain XPF.
Lifetime of the Excised Oligonucleotide-TFIIH Complex—UV
irradiation is known to inhibit transcription, and this was
ascribed to a physical barrier of UV photoproducts to the pro-
gression of RNA polymerase (2). The discovery that TFIIH is
both a core excision repair factor as well as a general transcription
factor (36) led to the realization that transcription initiationwould
also be inhibited as a result of sequestration of TFIIH in repair
complexes at damage sites. The recent finding that the excised
oligomer is in a tight complex with TFIIH led to the notion of a
third mechanism of transcription inhibition by sequestering
TFIIH in the post-excision complex (11). The finding that this
complex has a half-life of 3.3 h in vitro raised the possibility that
this mode of inhibitionmay have a serious impact on transcrip-
tion initiation as well as on the rate of excision repair. However,
there was the possibility that, under in vivo conditions, the
lifetime of this complex might be shorter and, hence, that the
rate of TFIIH release may not drastically affect transcription
initiation and excision repair kinetics. It is difficult to determine
the precise kinetics of release of CPD oligomers from TFIIH in
vivo because CPD repair is slow and continues at essentially the
same rate for 12 h in human cells, and, thus, excised oligonu-
cleotide-TFIIH complexes persist for as long because as the old
complexes disappear, newones are generated. In contrast,most
of the (6-4)PPs are excised in about 2 h in cells irradiated with
10 J/m2 (12) and, hence, any (6-4)PP-containing oligomer that
remains associated with TFIIH after about 2 h could be consid-
ered to represent the stability of the TFIIH-excised oligomer
complex. In fact, even though we do detect some (6-4)PP pri-
mary excision products (24–30-mers) 2 h post-irradiation, at
4 h the 20-mer degradation products predominate, and by
8 h, the (6-4)PP oligomers have mostly disappeared (data not
shown), indicating that the excised oligonucleotides are
degraded to small ( 10) nucleotides that are not detectable in
our experimental system. Moreover, as apparent from the size
range of the excised oligomer with both CPD and (6-4)PPs after
about 2 h of UV irradiation, fragments of 20 nucleotides in
size predominate, and these are nucleolytic degradation prod-
ucts of the primary excision oligomer and are no longer in com-
plex with TFIIH. Thus, it appears that, in vivo, the excised
oligomer bound to TFIIH is released fromTFIIH at a faster rate
than we observed previously in vitro (11). This release will
enable TFIIH to enter new rounds of repair and transcription,
and the contribution of TFIIH-30-mer complex to inhibition of
transcription is not as severe as the effect of TFIIH sequestra-
tion in preincision repair complexes. Identifying the factors that
promote the faster rate of release of excised oligomers fromTFIIH
in vivo compared with that in vitro will be important for devel-
oping comprehensive models of nucleotide excision repair and
for our understanding of how repair efficiency impacts human
disease, including skin cancer.
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Association of the Excised Oligonucleotide with RPA—Our
observation that excised oligomers form complexes with RPA
in vivo that are unique from those formed with TFIIH is iden-
tical to our recent report using cell-free extract in vitro (11).
Because the distribution of lengths of excised oligonucleotides
that are associated with RPA are generally shorter than those
bound toTFIIH, we assume that the binding of the oligomers to
RPA occurs after release fromTFIIH and after limited degrada-
tion by nucleases in the cell. As themajor single-stranded DNA
binding protein in humans and other eukaryotes (39, 40), it is
perhaps not too surprising that RPA binds to these small, dam-
age-containing oligomers. Whether there is physiological sig-
nificance to this association remains to be determined.
In conclusion, this study confirms the validity of the in vitro
data on human excision repair with regard to its relevance to in
vivo events and, importantly, it shows that damage is excised
from chromatin with a higher-order structure in the same way
that it is excised from a DNA duplex and provides insight into
damage recognition and product processing following dual
incision by nucleotide excision repair. We would also note that
the immunoprecipitation techniques employed here to isolate
excised DNA repair intermediates following UV irradiation
should be applicable to any DNA lesion that can be processed
by the excision repairmachinery. Furthermore, the high signal-
to-noise ratio our methodology generates should be of particu-
lar utility to cell culture and animal model systems in which the
biochemistry of excision repair may have been previously diffi-
cult to examine in vivo.
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